Printer Friendly

CASCADE MEDICAL SIGNS AGREEMENT WITH BOSTON ADVANCED TECHNOLOGIES

 CASCADE MEDICAL SIGNS AGREEMENT WITH BOSTON ADVANCED TECHNOLOGIES
 Companies Will Team Up on Non-Invasive Blood Monitors
 MINNEAPOLIS, Sept. 1 /PRNewswire/ -- Cascade Medical, Inc., Eden Prairie, Minn., has acquired exclusive worldwide rights to market a non- invasive blood glucose monitor under development by Boston Advanced Technologies (B.A.T.), Newton, Mass. Under the agreement, the two companies will team up to bring to the diabetes home monitoring industry a device that can measure blood glucose levels without drawing a blood sample.
 Currently, state-of-the-art blood glucose monitors, such as Cascade Medical's CheckMate(TM) System, require users to lance the skin, draw a blood sample and apply the blood to a disposable test strip. The new, patented technology, developed by Boston Advanced Technologies, utilizes laser diodes and fiber optics to direct near-infrared light through the skin. The reflected light is then analyzed to provide a measure of the glucose concentration in the blood. Next-generation products incorporating this non-invasive technology will be marketed as part of Cascade Medical's CheckMate line of diabetes products.
 The market for self blood glucose monitoring is one of the fastest growing areas in medical diagnostics, with a world market estimated at more than $800 million.
 "We consider this a highly significant, future-oriented agreement. While our current product is presently being used by a rapidly expanding customer base, providing non-invasive monitors has always been a key part of our strategic plan," said Richard E. Jones, Ph.D., president and CEO of Cascade Medical. "The 1990s will be a decade of many changes in the diabetes care industry, and we plan to be a leading force in bringing about these changes. This new association with Boston Advanced Technologies positions us to stay at the forefront of blood glucose monitoring equipment," said Jones.
 "This agreement is extremely important, and the partnership is a natural fit," said Richard H. Clarke, Ph.D., president and CEO of Boston Advanced Technologies. "We'll develop and manufacture the products, and Cascade Medical will bring valuable clinical and marketing experience to the equation."
 Established in 1989 and privately held, Boston Advanced Technologies currently has a contract from the National Aeronautics and Space Administration (NASA) to develop non-invasive monitors for blood analytes (glucose, cholesterol, lipids, etc.) for use in the manned spacefleet program.
 Cascade Medical, which is privately held, was founded in 1989 with the mission of becoming the premier supplier of diabetes products worldwide. In January 1992, Cascade Medical regained worldwide marketing rights to its system from the Wampole Laboratories division of New York-based Carter-Wallace, Inc., which had marketed it under the name Answer(R) Blood Glucose Monitoring System. Cascade Medical renamed the system CheckMate, and operates a 24-hour-a-day telephone customer service line at 1-800-525-6718. Cascade Medical's CheckMate System is designed for user convenience and safety and has several unique features, including a built-in lancing device and automatic calibration.
 -0- 9/1/92
 /CONTACT: Perry Ketchum of Ketchum & Metz, Inc., 612-349-2727, for Cascade Medical; or Gretchen Clarke of Boston Advanced Technologies, 617-964-3660/ CO: Cascade Medical, Inc.; Boston Advanced Technologies, Inc. ST: Minnesota, Massachusetts IN: MTC SU: JVN


KH -- MN001 -- 5320 09/01/92 10:02 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 1, 1992
Words:518
Previous Article:EDWARD D. COHEN NAMED DU PONT FELLOW
Next Article:BUFFETS, INC. ANNOUNCES NEW PRESIDENT
Topics:


Related Articles
CASCADE MEDICAL SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT
CASCADE MEDICAL SIGNS KOREAN DISTRIBUTION AGREEMENT STRONG GROWTH POTENTIAL IN PACIFIC RIM FOR CHECKMATE SYSTEM
CASCADE MEDICAL NAMES DIRECTOR OF INTERNATIONAL SALES; DOMAN, FORMERLY WITH AMERICAN STERILIZER COMPANY
CASCADE MEDICAL SIGNS MALAYSIAN DISTRIBUTION AGREEMENT; CONTINUES EXPANSION INTO PACIFIC RIM FOR CHECKMATE SYSTEM
CASCADE MEDICAL SIGNS DISTRIBUTION AGREEMENTS WITH THREE EUROPEAN COUNTRIES
Boston Scientific Signs Contract With Premier to Offer Medical Devices Under Cardiovascular Initiative.
Boston Scientific Signs Agreement for Advanced Imaging and Navigation Technology.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters